82 related articles for article (PubMed ID: 6889870)
1. Identification of the major degradation product of 1-propyl-3,5-diethyl-6-chlorouracil in rabbits and mechanism of the formation of bicyclic barbituric acid metabolites.
Kaul R; Hempel B
Arzneimittelforschung; 1982; 32(7):722-3. PubMed ID: 6889870
[TBL] [Abstract][Full Text] [Related]
2. [Identification of a third S-containing metabolite of 1-allyl-3,5-diethyl-6-chlorouracil and mechanism of formation of SCH3-metabolites (author's transl)].
Kaul R; Kiefer G; Hempel B
Arzneimittelforschung; 1982; 32(6):610-2. PubMed ID: 7202365
[TBL] [Abstract][Full Text] [Related]
3. 2-14C-1-Allyl-3,5-diethyl-6-chlorouracil II: Isolation and structures of the major sulfur-free and three minor sulfur-containing metabolites and mechanism of biotransformation.
Kaul R; Hempel B; Kiefer G
J Pharm Sci; 1982 Aug; 71(8):897-900. PubMed ID: 7120092
[TBL] [Abstract][Full Text] [Related]
4. [Identification of two S-containing metabolites of 1-allyl-3,5-diethyl-6-chlorouracil in rabbit urine (author's transl)].
Kaul R; Hempel B; Schäfer W
Arzneimittelforschung; 1976 Apr; 26(4):489-99. PubMed ID: 989004
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
Dain JG; Bhuta SI; Coombs RA; Talbot KC; Dugger HA
Drug Metab Dispos; 1980; 8(4):247-52. PubMed ID: 6105059
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the biotransformation of 5-vinyl-5-(1-methylbutyl)- and 5-vinyl-5-(1-ethyl-propyl)-barbituric acid (author's transl)].
Preuss FR; Gutzler H
Arzneimittelforschung; 1976; 26(11):2080-4. PubMed ID: 1037252
[TBL] [Abstract][Full Text] [Related]
7. Structure of a novel sulphur-containing metabolite of Acluracil (1-allyl-3,5-diethyl-6-chlorouracil).
Kaul R; Hempel B; Kiefer G
Xenobiotica; 1982 Aug; 12(8):495-8. PubMed ID: 7147995
[No Abstract] [Full Text] [Related]
8. [Biotransformation of [2-14C]-1-alkyl-3,5-diethyl-6-chlorouracil and synthesis of some possible degradation products (author's transl)].
Kiefer G; Kaul R; Keppeler K; Hempel B
Arch Pharm (Weinheim); 1982 May; 315(5):444-50. PubMed ID: 7103697
[No Abstract] [Full Text] [Related]
9. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
Dumasia MC
Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
Agostini O; Bonacchi G; Coppini G; Toja E; Triolo A; Manzini S; Pieraccini G; Moneti G
Drug Metab Dispos; 1994; 22(2):259-68. PubMed ID: 7516853
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
Bernauer U; Amberg A; Scheutzow D; Dekant W
Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation and branchial excretion of 17 alpha-methyltestosterone in trout.
Cravedi JP; Delous G; Debrauwer L; Prome D
Drug Metab Dispos; 1993; 21(2):377-85. PubMed ID: 8097712
[TBL] [Abstract][Full Text] [Related]
14. INVESTIGATIONS ON THE MECHANISM OF THE DEGRADATION OF 5-ALLYL-5-(BETA-HYDROXYPROPYL)-BARBITURIC ACID IN THE ORGANISM. METABOLISM OF 1-METHYL-5-ALLYL-5-(BETA-HYDROXYPROPYL)-BARBITURIC ACIDS IN THE ORGANISM OF RABBITS.
BOBRANSKI B; KONIECZNY M; SYPER L
Arch Immunol Ther Exp (Warsz); 1962; 10():811-7. PubMed ID: 14054135
[No Abstract] [Full Text] [Related]
15. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
16. Analysis of bacteria degradation products of methyl parathion by liquid chromatography/electrospray time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
Liu J; Wang L; Zheng L; Wang X; Lee FS
J Chromatogr A; 2006 Dec; 1137(2):180-7. PubMed ID: 17126847
[TBL] [Abstract][Full Text] [Related]
17. [Study on metabolite of 5-ethyl-5-(para-fluorobenzoylpropyl) barbituric acid in rabbits].
Fu G; Dong SN; Sun SW; Ma YP
Yao Xue Xue Bao; 1995; 30(8):610-4. PubMed ID: 8571781
[TBL] [Abstract][Full Text] [Related]
18. [On the pharmacology of 5-ethyl-5(3-hydroxyisoamyl)-barbituric acid--a breakdown product of 5-ethyl-5-isoamyl-barbituric acid].
Irrgang K
Arzneimittelforschung; 1965 Jun; 15(6):688-91. PubMed ID: 5899249
[No Abstract] [Full Text] [Related]
19. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
[TBL] [Abstract][Full Text] [Related]
20. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
Li AC; Ding J; Jiang X; Denissen J
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]